secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0001493152-23-031972
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals reappoints Carter Ward as CFO effective Sept 5, 2023
--------------------------------------------------------------------------

- Carter Ward reappointed CFO, secretary, treasurer; previously served from July 2009 to May 2021.
- Base salary $275,000; guaranteed annual bonus 20% of base; performance bonus up to 30%.
- Granted options to purchase 3,000,000 shares at closing price on effective date.
- Severance: 2 months salary per year of service (max 12 months) if terminated without cause or for good reason.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223031972/0001493152-23-031972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223031972/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer